SARS-CoV-2 Mpro-IN-25

SARS-CoV-2 Mpro-IN-25 (Compound 3a) is a SARS-CoV-2 protease inhibitor with an IC50 value of 0.26 μM. SARS-CoV-2 Mpro-IN-25 exhibits antiviral activity and can be used in pneumonia-related research[1].

Product Specifications

CAS Number

[2205006-23-9]

UNSPSC

12352005

Target

Virus Protease

Type

Reference compound

Related Pathways

Anti-infection

Field of Research

Infection; Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/sars-cov-2-mpro-in-25.html

Smiles

O=C(C1=CC(O)=C(C(O)=C1)O)NC2=CC=C(C=C2)F

Molecular Formula

C13H10FNO4

Molecular Weight

263.22

References & Citations

[1]de Carvalho MAG, et al. Synthesis, in vitro and in silico evaluation of gallamide and selenogallamide derivatives as inhibitors of the SARS-CoV-2 main protease. Arch Pharm (Weinheim) . 2024 Aug 15:e2400253.